Société Medtronic, Inc. Nyse
Actions
US5850551061
Equipement, fournitures et distribution médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
10:36 | Edwards Lifesciences Corporation : L’histoire se poursuit | |
17/04 | MEDTRONIC PLC : Baird toujours neutre sur le dossier | ZM |
Métier
- chirurgies générale et mini-invasive (28,8%) : équipements chirurgicaux, systèmes de surveillance intra-opératoire, systèmes de ventilation, etc. ;
- gestion du rythme cardiaque (18,6%) : stimulateurs cardiaques implantables, défibrillateurs implantables et défibrillateurs externes automatiques, sondes d'ablation cardiaque, etc. ;
- maladies vasculaires et chirurgie cardiaque (17,4%) : stents coronariens, endoprothèses pour les pathologies de l'aorte, systèmes de protection distale, cathéters, prothèses valvulaires cardiaques, matériel d'autotransfusion, dispositifs d'ablation cardiaque, etc. ;
- troubles rachidiens (14,1%) : prothèses rachidiennes, prothèses discales, systèmes de stimulation cérébrale, technologies de greffe osseuse et de chirurgie rachidienne mini-invasive, etc. Par ailleurs, le groupe développe des systèmes de navigation chirurgicale guidée par imagerie médicale ;
- maladies neurovasculaire, oto-rhino-laryngologie (ORL) et pelviennes (8,2%) ;
- gestion du diabète (7,4%) : systèmes internes et externes de surveillance de la glycémie et pompes à insuline ;
- maladies neurologiques (5,5%) : produits de neurostimulation et d'administration de médicaments par pompe, outils de diagnostic, etc.
La répartition géographique du CA est la suivante : Irlande (0,3%), Etats-Unis (50,9%) et autres (48,8%).
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Cardiovascular
37,1
%
| 11 423 | 36,1 % | 11 573 | 37,1 % | +1,31 % |
Neuroscience
28,7
%
| 8 784 | 27,7 % | 8 959 | 28,7 % | +1,99 % |
Medical Surgical
27,0
%
| 9 141 | 28,8 % | 8 433 | 27,0 % | -7,75 % |
Diabetes
7,2
%
| 2 338 | 7,4 % | 2 262 | 7,2 % | -3,25 % |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
52,4
%
| 16 134 | 50,9 % | 16 373 | 52,4 % | +1,48 % |
Non-United States Developed Markets
29,8
%
| 10 025 | 31,6 % | 9 310 | 29,8 % | -7,13 % |
Emerging Markets
17,4
%
| 5 426 | 17,1 % | 5 446 | 17,4 % | +0,37 % |
Ireland
0,3
%
| 101 | 0,3 % | 98 | 0,3 % | -2,97 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Geoffrey Martha
CEO | Chief Executive Officer | 54 | 26/01/15 |
Karen Parkhill
DFI | Director of Finance/CFO | 58 | 01/06/16 |
Gregory Smith
COO | Chief Operating Officer | 60 | 01/04/21 |
Laura Mauri
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/18 |
Chief Tech/Sci/R&D Officer | 63 | 01/06/23 | |
Investor Relations Contact | - | 01/06/99 | |
Raman Venkatesh
PRN | Corporate Officer/Principal | - | 21/02 |
Robert White
PRN | Corporate Officer/Principal | 61 | 01/01/15 |
Yushao Gu
PRN | Corporate Officer/Principal | 55 | 01/01/15 |
Corporate Officer/Principal | 53 | 01/05/18 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Scott Donnelly
BRD | Director/Board Member | 62 | 01/01/13 |
Kendall Powell
BRD | Director/Board Member | 70 | 01/01/07 |
Randall Hogan
BRD | Director/Board Member | 68 | 01/01/15 |
Denise O'Leary
BRD | Director/Board Member | 66 | 01/01/00 |
Craig Arnold
BRD | Director/Board Member | 64 | 26/01/15 |
Kevin Lofton
BRD | Director/Board Member | 69 | 15/09/20 |
Lidia Fonseca
BRD | Director/Board Member | 55 | 27/06/22 |
Geoffrey Martha
CEO | Chief Executive Officer | 54 | 26/01/15 |
Elizabeth Nabel
BRD | Director/Board Member | 72 | 01/01/14 |
Gregory Lewis
BRD | Director/Board Member | 53 | 26/06/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 1 327 822 539 | 1 325 378 582 ( 99,82 %) | 0 | 99,82 % |
Participations
Nom | Actions | % | Valorisation |
---|---|---|---|
5 868 916 | 16,42% | 30 929 187 $ |
Coordonnées société
Sociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. |
Medical Specialties
|
Covidien Group SARL
Covidien Group SARL Medical SpecialtiesHealth Technology Part of Medtronic Plc, Covidien Group SARL is a Luxembourger company that manufactures medical devices, diagnostic imaging agents, and pharmaceuticals. The private company is based in Luxembourg, Luxembourg. |
Medical Specialties
|
Covidien LP
Covidien LP Medical SpecialtiesHealth Technology Covidien LP manufactures and distributes medical devices. Its products include disposable medical supplies, monitoring equipment, innovative wound closure products, advanced surgical devices, medical instruments and bulk analgesic pharmaceuticals. The company is headquartered in Mansfield, MA. |
Medical Specialties
|
Medtronic International Technology, Inc.
| |
Arterial Vascular Engineering Canada Co.
| |
Arterial Vascular Engineering UK Ltd.
Arterial Vascular Engineering UK Ltd. Financial ConglomeratesFinance Part of Medtronic Plc, Arterial Vascular Engineering UK Ltd. provides investment services. The private company is based in London, UK. Founded in 1995. |
Financial Conglomerates
|
Medtronic AB
| |
Medtronic Korea Co. Ltd.
Medtronic Korea Co. Ltd. Hospital/Nursing ManagementHealth Services Medtronic Korea Co., Ltd. engages in the manufacture and sale of medical products. It operates through the follow businesses: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabettes. The company was founded on June 21. 2000 and is headquartered in Seoul, South Korea. |
Hospital/Nursing Management
|
Medtronic Bakken Research Center BV
Medtronic Bakken Research Center BV Medical SpecialtiesHealth Technology Part of Medtronic Plc, Medtronic Bakken Research Center BV is a Dutch company that specializes in providing innovative products, services, and solutions to help spine surgeons overcome their biggest challenges. The private company is based in Maastricht, Netherlands. The company also offers products for neurological procedures, surgery, neurostimulation, and drug infusion systems for chronic pain and severe spasticity. Founded in 1987, the company offers care management services that provide remote patient monitoring programs to improve patient health and deliver economic benefits to the healthcare system. |
Medical Specialties
|
Secteur
Ventes par activité
Ventes par région
Varia. 1 janv. | Capi. | |
---|---|---|
-2,73 % | 186 Md | |
-4,08 % | 67,57 Md | |
+5,99 % | 50,7 Md | |
+15,32 % | 47,2 Md | |
-0,45 % | 39,72 Md | |
+6,60 % | 27,48 Md | |
-1,11 % | 25,65 Md | |
-0,76 % | 24,82 Md | |
+13,37 % | 24,97 Md |
- Bourse
- Actions
- Action MDT
- Action
- Société Medtronic, Inc.